Paul W. Armstrong

Paul W. Armstrong

Edmonton, AB, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 375 publications

Inflammatory Biomarkers and ECG Repolarization Metrics: Sudden Death in Heart Failure With Reduced Ejection Fraction.

Inflammatory Biomarkers and ECG Repolarization Metrics: Sudden Death in Heart Failure With Reduced Ejection Fraction.

Journal: JACC. Advances

Published: March 31, 2026

Effects of Baseline Q Waves and Reperfusion Strategy on Outcomes in Patients With ST-elevation Myocardial Infarction: Insights From the Vital Heart Response Registry.

Effects of Baseline Q Waves and Reperfusion Strategy on Outcomes in Patients With ST-elevation Myocardial Infarction: Insights From the Vital Heart Response Registry.

Journal: The Canadian journal of cardiology

Published: January 14, 2026

Effects of Baseline Q Waves and Reperfusion Strategy on Outcomes in Patients With ST-elevation Myocardial Infarction: Insights From the Vital Heart Response Registry.

Effects of Baseline Q Waves and Reperfusion Strategy on Outcomes in Patients With ST-elevation Myocardial Infarction: Insights From the Vital Heart Response Registry.

Journal: The Canadian journal of cardiology

Published: January 14, 2026

Transfer of Patients With ST-Elevation MI for Reperfusion-It's About Time.

Transfer of Patients With ST-Elevation MI for Reperfusion-It's About Time.

Journal: JAMA cardiology

Published: January 07, 2026

Primary percutaneous coronary intervention within the first hour: Insights from early-treated patients with ST-elevation myocardial infarction.

Primary percutaneous coronary intervention within the first hour: Insights from early-treated patients with ST-elevation myocardial infarction.

Journal: American heart journal

Published: November 13, 2025

Primary Percutaneous Coronary Intervention within the First Hour: Insights from Early-Treated Patients with ST-Elevation Myocardial Infarction.

Primary Percutaneous Coronary Intervention within the First Hour: Insights from Early-Treated Patients with ST-Elevation Myocardial Infarction.

Journal: American heart journal

Published: November 13, 2025

Phenomapping in Heart Failure With Reduced Ejection Fraction to Identify Subpopulations With High Residual Risk: A VICTORIA Substudy.

Phenomapping in Heart Failure With Reduced Ejection Fraction to Identify Subpopulations With High Residual Risk: A VICTORIA Substudy.

Journal: Circulation. Heart failure

Published: October 08, 2025

Rescue percutaneous coronary intervention in the pharmaco-invasive era of ST-elevation myocardial infarction: insights from the STREAM-2 trial.

Rescue percutaneous coronary intervention in the pharmaco-invasive era of ST-elevation myocardial infarction: insights from the STREAM-2 trial.

Journal: European heart journal. Acute cardiovascular care

Published: August 12, 2025

Geographic region variation in patient characteristics, clinical outcomes and treatment of HFrEF in the VICTORIA trial.

Geographic region variation in patient characteristics, clinical outcomes and treatment of HFrEF in the VICTORIA trial.

Journal: ESC heart failure

Published: August 07, 2025

Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trials.

Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trials.

Journal: Lancet (London, England)

Published: July 28, 2025

Assessing Benefit in Patients With Heart Failure and Reduced Ejection Fraction: Analysis of the VICTORIA Trial Using Novel Prognostic Risk Stratification.

Assessing Benefit in Patients With Heart Failure and Reduced Ejection Fraction: Analysis of the VICTORIA Trial Using Novel Prognostic Risk Stratification.

Journal: Journal of cardiac failure

Published: April 22, 2025

Worsening Kidney Function and Cardiovascular Outcomes in Type 2 Diabetes and Atherosclerotic Disease.

Worsening Kidney Function and Cardiovascular Outcomes in Type 2 Diabetes and Atherosclerotic Disease.

Journal: JACC. Advances

Published: March 05, 2025

Showing 1-12 of 375

Last Updated: 09/26/2026